SOC Telemed (SOC Telemed) Interest Expense : $ Mil (TTM As of Dec. 2021)

View and export this data going back to 2020. Start your Free Trial

What is SOC Telemed Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. SOC Telemed's interest expense for the six months ended in Dec. 2021 was $ -9.03 Mil. SOC Telemed does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2021.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. SOC Telemed's Operating Income for the six months ended in Dec. 2021 was $ -56.26 Mil. SOC Telemed's Interest Expense for the six months ended in Dec. 2021 was $ -9.03 Mil. SOC Telemed did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

SOC Telemed Interest Expense Historical Data

The historical data trend for SOC Telemed's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOC Telemed Interest Expense Chart

SOC Telemed Annual Data

Trend

Dec19

Dec20

Dec21

Interest Expense

-10.31

-12.23

-9.03

SOC Telemed Semi-Annual Data
	Dec19	Dec20	Dec21
Interest Expense	-10.31	-12.23	-9.03

SOC Telemed Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

SOC Telemed (NAS:TLMDW) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

SOC Telemed's Interest Expense for the six months ended in Dec. 2021 was $-9.03 Mil. Its Operating Income for the six months ended in Dec. 2021 was $-56.26 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2021 was $86.75 Mil.

SOC Telemed's Interest Coverage for the quarter that ended in Dec. 2021 is calculated as

SOC Telemed did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

SOC Telemed (SOC Telemed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SOC Telemed Inc (NAS:TLMDW) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1768 Business Center Drive, Suite 100, Reston, VA, USA, 20190

Website

https://www.soctelemed.com

SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.

Executives

David R. Fletcher	officer: Interim CFO	C/O SOC TELEMED, INC., 1768 BUSINESS CENTER DRIVE, SUITE 100, RESTON VA 20190
David Mikula	officer: Chief Operating Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Gyasi C. Chisley	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Christopher M. Gallagher	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Steven J Shulman	director	1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Christopher K Knibb	officer: Chief Financial Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Warburg Pincus Partners Ii, L.p.	director, 10 percent owner	450 LEXINGTON AVENUE, C/O WARBURG PINCUS LLC, NEW YORK NY 10017
Anne Mcgeorge	director	C/O MAGENTA THERAPEUTICS, INC., 100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE MA 02139
Wpxi Finance, Lp	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Wpxi Gp, L.p.	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Warburg Pincus & Co.	director, 10 percent owner	450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Amr Kronfol	director	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Joseph P Greskoviak	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Sean Banerjee	officer: Chief Technology Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
John W. Kalix	director, officer: Chief Executive Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190